Candel Therapeutics Inc. (NASDAQ: CADL)
$7.29
+0.6700 ( +10.12% ) 733.4K
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Market Data
Open
$7.29
Previous close
$6.62
Volume
733.4K
Market cap
$216.92M
Day range
$6.47 - $7.34
52 week range
$0.66 - $14.30
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 10 | Jan 12, 2024 |
| 8-k | 8K-related | 12 | Jan 03, 2024 |
| 8-k | 8K-related | 12 | Dec 15, 2023 |
| 8-k | 8K-related | 14 | Dec 12, 2023 |
| 4 | Insider transactions | 1 | Nov 30, 2023 |
| 4 | Insider transactions | 1 | Nov 30, 2023 |
| 4 | Insider transactions | 1 | Nov 30, 2023 |
| 4 | Insider transactions | 1 | Nov 30, 2023 |
| 4 | Insider transactions | 1 | Nov 30, 2023 |
| 4 | Insider transactions | 1 | Nov 28, 2023 |